Immune-mediated Colitis (IMC) Clinical Trials in Pittsburgh, Pennsylvania

Healthy-donor Microbiome MTP-101-C in Steroid Relapse/Refractory Immune-related Cutaneous Adverse Events (irCAEs) and Immune-mediated Colitis (IMC)